Approval · Notice of Compliance 28482 · 2022
RISEDRONATE: Notice of Compliance 28482
Issued June 28, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28482
- Date
- June 28, 2022
- Company
- Sanis Health Inc.Brampton, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Administrative: Licensing Agreement Between Two Companies
- Canadian reference product
- ACTONEL (Procter & Gamble Pharmaceuticals Canada, Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RISEDRONATE | 02528460 | Marketed |
Medicinal ingredients
- RISEDRONATE SODIUM 150 MG per TAB